BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33420762)

  • 21. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.
    Wagner BE; Langstraat CL; McGree ME; Weaver AL; Sarangi S; Mokri B; Dowdy SC; Cliby WA; Kumar A; Bakkum-Gamez JN
    Gynecol Oncol; 2019 Feb; 152(2):286-292. PubMed ID: 30471900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
    Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
    J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.
    Enga KF; Rye-Holmboe I; Hald EM; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
    J Thromb Haemost; 2015 Jan; 13(1):10-6. PubMed ID: 25330989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.
    Graul A; Latif N; Zhang X; Dean LT; Morgan M; Giuntoli R; Burger R; Kim S; Ko E
    Int J Gynecol Cancer; 2017 Mar; 27(3):581-587. PubMed ID: 28187092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
    Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S
    J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies.
    Matthay ZA; Flanagan CP; Sanders K; Smith EJ; Lancaster EM; Gasper WJ; Kornblith LZ; Hiramoto JS; Conte MS; Iannuzzi JC
    J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):585-593.e2. PubMed ID: 34637952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
    Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
    Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism and subsequent permanent work-related disability.
    Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
    J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The occurrence of venous thromboembolism in cancer patients following major surgery.
    Toledano TH; Kondal D; Kahn SR; Tagalakis V
    Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.
    Trugilho IA; Renni MJP; Medeiros GC; Thuler LCS; Bergmann A
    Thromb Res; 2020 Jan; 185():49-54. PubMed ID: 31759190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort.
    Blix K; Gran OV; Severinsen MT; Cannegieter SC; Jensvoll H; Overvad K; Hammerstrøm J; Tjønneland A; Naess IA; Braekkan SK; Rosendaal FR; Kristensen SR; Hansen JB
    J Thromb Haemost; 2018 Jul; 16(7):1327-1335. PubMed ID: 29691978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index.
    Zöller B; Pirouzifard M; Sundquist J; Sundquist K
    Thromb Haemost; 2019 Jan; 119(1):48-55. PubMed ID: 30597499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review.
    Moufarrij S; Sassine D; Basaran D; Jewell EL
    Gynecol Oncol; 2023 Mar; 170():167-171. PubMed ID: 36701837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
    Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L
    Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
    Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
    Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
    Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
    J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.